img

Global Thiabendazole Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture

Publisher : MRA | Format : PDF

Global Thiabendazole Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Thiabendazole market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the forecast period 2023-2033.
The United States market for Thiabendazole is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The China market for Thiabendazole is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The Europe market for Thiabendazole is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The global key manufacturers of Thiabendazole include Kenvos Biotech, Merial U.S., Jiangsu Noon Crop Science, CTS Group, AKITA KONNO CO., LTD and Shanghai Skyblue Chemical Co., Ltd., etc. In 2022, the global top five players had a share approximately % in sales volume, and in term of revenue of Thiabendazole, the top five companies hold a share nearly %.
In terms of production side, this report researches the Thiabendazole capacity, production, growth rate, market share by manufacturers, region level and country level, from 2018 to 2023, and forecast to 2033.
In terms of sales (consumption) side, this report focuses on the sales of Thiabendazole by region (Countries), company, type and application. from 2018 to 2023 and forecast to 2033.
The global Thiabendazole market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by type segment of the global Thiabendazole market. These figures have been provided in terms of both revenue and volume for the period 2018-2033. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.



By Company


Kenvos Biotech
Merial U.S.
Jiangsu Noon Crop Science
CTS Group
AKITA KONNO CO., LTD
Shanghai Skyblue Chemical Co., Ltd.
By Type
Powder
Liquid
By Application
Preservative
Antifungal Agent
Antiparasitic Agent
Other

Production by Region


North America
Europe
China
Japan
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Thiabendazole in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Thiabendazole production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4Detailed analysis of Thiabendazole manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 9China by company, by type and by application, sales, and revenue for each segment.
Chapter 10APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 11Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 12Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Thiabendazole sales, revenue, price, gross margin, and recent development, etc.
Chapter 13Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 14Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Thiabendazole Definition
1.2 Market by Type
1.2.1 Global Thiabendazole Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Powder
1.2.3 Liquid
1.3 Market by Application
1.3.1 Global Thiabendazole Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Preservative
1.3.3 Antifungal Agent
1.3.4 Antiparasitic Agent
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Thiabendazole Sales
2.1 Global Thiabendazole Revenue Estimates and Forecasts 2018-2033
2.2 Global Thiabendazole Revenue by Region: 2018 VS 2022 VS 2033
2.3 Global Thiabendazole Revenue by Region
2.3.1 Global Thiabendazole Revenue by Region (2018-2023)
2.3.2 Global Thiabendazole Revenue by Region (2024-2033)
2.4 Global Thiabendazole Sales Quantity Estimates and Forecasts 2018-2033
2.5 Global Thiabendazole Sales Quantity by Region: 2018 VS 2022 VS 2033
2.6 Global Thiabendazole Sales Quantity by Region
2.6.1 Global Thiabendazole Sales Quantity by Region (2018-2023)
2.6.2 Global Thiabendazole Sales Quantity by Region (2024-2033)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Global Production (Based on Production Site)
3.1 Global Thiabendazole Production Value by Region: 2018 VS 2022 VS 2033
3.2 Global Thiabendazole Production Value by Region
3.2.1 Global Thiabendazole Historic Production Value by Region (2018-2023)
3.2.2 Global Thiabendazole Forecasted Production Value by Region (2024-2033)
3.3 Global Thiabendazole Production Capacity (2018-2033)
3.4 Global Thiabendazole Production by Region: 2018 VS 2022 VS 2033
3.5 Global Thiabendazole Production by Region
3.5.1 Global Thiabendazole Historic Production by Region (2018-2023)
3.5.2 Global Thiabendazole Forecasted Production by Region (2024-2033)
3.5.3 North America
3.5.4 Europe
3.5.5 Japan
3.5.6 China
3.5.7 South Korea
3.5.8 India
4 Competition by Manufacturers
4.1 Global Thiabendazole Sales Quantity by Manufacturers
4.1.1 Global Thiabendazole Sales Quantity by Manufacturers (2018-2023)
4.1.2 Global Thiabendazole Sales Quantity Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Companies by Thiabendazole Sales in 2022
4.2 Global Thiabendazole Revenue by Manufacturers
4.2.1 Global Thiabendazole Revenue by Manufacturers (2018-2023)
4.2.2 Global Thiabendazole Revenue Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Thiabendazole Revenue in 2022
4.3 Global Thiabendazole Sales Price by Manufacturers
4.4 Global Key Players of Thiabendazole, Industry Ranking, 2021 VS 2022
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Thiabendazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Thiabendazole, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Thiabendazole, Product Offered and Application
4.8 Global Key Manufacturers of Thiabendazole, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Estimates and Forecasts by Type
5.1 Global Thiabendazole Sales Quantity by Type
5.1.1 Global Thiabendazole Historical Sales Quantity by Type (2018-2023)
5.1.2 Global Thiabendazole Forecasted Sales Quantity by Type (2024-2033)
5.1.3 Global Thiabendazole Sales Quantity Market Share by Type (2018-2033)
5.2 Global Thiabendazole Revenue by Type
5.2.1 Global Thiabendazole Historical Revenue by Type (2018-2023)
5.2.2 Global Thiabendazole Forecasted Revenue by Type (2024-2033)
5.2.3 Global Thiabendazole Revenue Market Share by Type (2018-2033)
5.3 Global Thiabendazole Price by Type
5.3.1 Global Thiabendazole Price by Type (2018-2023)
5.3.2 Global Thiabendazole Price Forecast by Type (2024-2033)
6 Market Size by Application
6.1 Global Thiabendazole Sales Quantity by Application
6.1.1 Global Thiabendazole Historical Sales Quantity by Application (2018-2023)
6.1.2 Global Thiabendazole Forecasted Sales Quantity by Application (2024-2033)
6.1.3 Global Thiabendazole Sales Quantity Market Share by Application (2018-2033)
6.2 Global Thiabendazole Revenue by Application
6.2.1 Global Thiabendazole Historical Revenue by Application (2018-2023)
6.2.2 Global Thiabendazole Forecasted Revenue by Application (2024-2033)
6.2.3 Global Thiabendazole Revenue Market Share by Application (2018-2033)
6.3 Global Thiabendazole Price by Application
6.3.1 Global Thiabendazole Price by Application (2018-2023)
6.3.2 Global Thiabendazole Price Forecast by Application (2024-2033)
7 North America
7.1 North America Thiabendazole Sales by Company
7.1.1 North America Thiabendazole Revenue by Company (2018-2023)
7.1.2 North America Thiabendazole Sales Quantity by Company (2018-2023)
7.2 North America Thiabendazole Market Size by Type
7.2.1 North America Thiabendazole Sales Quantity by Type (2018-2033)
7.2.2 North America Thiabendazole Revenue by Type (2018-2033)
7.3 North America Thiabendazole Market Size by Application
7.3.1 North America Thiabendazole Sales Quantity by Application (2018-2033)
7.3.2 North America Thiabendazole Revenue by Application (2018-2033)
7.4 North America Thiabendazole Market Size by Country
7.4.1 North America Thiabendazole Revenue by Country: 2018 VS 2022 VS 2033
7.4.2 North America Thiabendazole Revenue by Country (2018-2033)
7.4.3 North America Thiabendazole Sales Quantity by Country (2018-2033)
7.4.4 U.S.
7.4.5 Canada
8 Europe
8.1 Europe Thiabendazole Sales by Company
8.1.1 Europe Thiabendazole Sales Quantity by Company (2018-2023)
8.1.2 Europe Thiabendazole Revenue by Company (2018-2023)
8.2 Europe Thiabendazole Market Size by Type
8.2.1 Europe Thiabendazole Sales Quantity by Type (2018-2033)
8.2.2 Europe Thiabendazole Revenue by Type (2018-2033)
8.3 Europe Thiabendazole Market Size by Application
8.3.1 Europe Thiabendazole Sales Quantity by Application (2018-2033)
8.3.2 Europe Thiabendazole Revenue by Application (2018-2033)
8.4 Europe Thiabendazole Market Size by Country
8.4.1 Europe Thiabendazole Revenue by Country: 2018 VS 2022 VS 2033
8.4.2 Europe Thiabendazole Revenue by Country (2018-2033)
8.4.3 Europe Thiabendazole Sales Quantity by Country (2018-2033)
8.4.4 Germany
8.4.5 France
8.4.6 U.K.
8.4.7 Italy
8.4.8 Russia
9 China
9.1 China Thiabendazole Sales by Company
9.1.1 China Thiabendazole Sales Quantity by Company (2018-2023)
9.1.2 China Thiabendazole Revenue by Company (2018-2023)
9.2 China Thiabendazole Market Size by Type
9.2.1 China Thiabendazole Sales Quantity by Type (2018-2033)
9.2.2 China Thiabendazole Revenue by Type (2018-2033)
9.3 China Thiabendazole Market Size by Application
9.3.1 China Thiabendazole Sales Quantity by Application (2018-2033)
9.3.2 China Thiabendazole Revenue by Application (2018-2033)
10 APAC (excluding China)
10.1 APAC Thiabendazole Sales by Company
10.1.1 APAC Thiabendazole Sales Quantity by Company (2018-2023)
10.1.2 APAC Thiabendazole Revenue by Company (2018-2023)
10.2 APAC Thiabendazole Market Size by Type
10.2.1 APAC Thiabendazole Sales Quantity by Type (2018-2033)
10.2.2 APAC Thiabendazole Revenue by Type (2018-2033)
10.3 APAC Thiabendazole Market Size by Application
10.3.1 APAC Thiabendazole Sales Quantity by Application (2018-2033)
10.3.2 APAC Thiabendazole Revenue by Application (2018-2033)
10.4 APAC Thiabendazole Market Size by Region
10.4.1 APAC Thiabendazole Revenue by Region: 2018 VS 2022 VS 2033
10.4.2 APAC Thiabendazole Revenue by Region (2018-2033)
10.4.3 APAC Thiabendazole Sales Quantity by Region (2018-2033)
10.4.4 Japan
10.4.5 South Korea
10.4.6 China Taiwan
10.4.7 Southeast Asia
10.4.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Thiabendazole Sales by Company
11.1.1 Middle East, Africa and Latin America Thiabendazole Sales Quantity by Company (2018-2023)
11.1.2 Middle East, Africa and Latin America Thiabendazole Revenue by Company (2018-2023)
11.2 Middle East, Africa and Latin America Thiabendazole Market Size by Type
11.2.1 Middle East, Africa and Latin America Thiabendazole Sales Quantity by Type (2018-2033)
11.2.2 Middle East, Africa and Latin America Thiabendazole Revenue by Type (2018-2033)
11.3 Middle East, Africa and Latin America Thiabendazole Market Size by Application
11.3.1 Middle East, Africa and Latin America Thiabendazole Sales Quantity by Application (2018-2033)
11.3.2 Middle East, Africa and Latin America Thiabendazole Revenue by Application (2018-2033)
11.4 Middle East, Africa and Latin America Thiabendazole Market Size by Country
11.4.1 Middle East, Africa and Latin America Thiabendazole Revenue by Country: 2018 VS 2022 VS 2033
11.4.2 Middle East, Africa and Latin America Thiabendazole Revenue by Country (2018-2033)
11.4.3 Middle East, Africa and Latin America Thiabendazole Sales Quantity by Country (2018-2033)
11.4.4 Brazil
11.4.5 Mexico
11.4.6 Turkey
11.4.7 Israel
11.4.8 GCC Countries
12 Company Profiles
12.1 Kenvos Biotech
12.1.1 Kenvos Biotech Company Information
12.1.2 Kenvos Biotech Overview
12.1.3 Kenvos Biotech Thiabendazole Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
12.1.4 Kenvos Biotech Thiabendazole Products and Services
12.1.5 Kenvos Biotech Thiabendazole SWOT Analysis
12.1.6 Kenvos Biotech Recent Developments
12.2 Merial U.S.
12.2.1 Merial U.S. Company Information
12.2.2 Merial U.S. Overview
12.2.3 Merial U.S. Thiabendazole Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
12.2.4 Merial U.S. Thiabendazole Products and Services
12.2.5 Merial U.S. Thiabendazole SWOT Analysis
12.2.6 Merial U.S. Recent Developments
12.3 Jiangsu Noon Crop Science
12.3.1 Jiangsu Noon Crop Science Company Information
12.3.2 Jiangsu Noon Crop Science Overview
12.3.3 Jiangsu Noon Crop Science Thiabendazole Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
12.3.4 Jiangsu Noon Crop Science Thiabendazole Products and Services
12.3.5 Jiangsu Noon Crop Science Thiabendazole SWOT Analysis
12.3.6 Jiangsu Noon Crop Science Recent Developments
12.4 CTS Group
12.4.1 CTS Group Company Information
12.4.2 CTS Group Overview
12.4.3 CTS Group Thiabendazole Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
12.4.4 CTS Group Thiabendazole Products and Services
12.4.5 CTS Group Thiabendazole SWOT Analysis
12.4.6 CTS Group Recent Developments
12.5 AKITA KONNO CO., LTD
12.5.1 AKITA KONNO CO., LTD Company Information
12.5.2 AKITA KONNO CO., LTD Overview
12.5.3 AKITA KONNO CO., LTD Thiabendazole Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
12.5.4 AKITA KONNO CO., LTD Thiabendazole Products and Services
12.5.5 AKITA KONNO CO., LTD Thiabendazole SWOT Analysis
12.5.6 AKITA KONNO CO., LTD Recent Developments
12.6 Shanghai Skyblue Chemical Co., Ltd.
12.6.1 Shanghai Skyblue Chemical Co., Ltd. Company Information
12.6.2 Shanghai Skyblue Chemical Co., Ltd. Overview
12.6.3 Shanghai Skyblue Chemical Co., Ltd. Thiabendazole Sales Quantity, Revenue, Price and Gross Margin (2018-2023)
12.6.4 Shanghai Skyblue Chemical Co., Ltd. Thiabendazole Products and Services
12.6.5 Shanghai Skyblue Chemical Co., Ltd. Thiabendazole SWOT Analysis
12.6.6 Shanghai Skyblue Chemical Co., Ltd. Recent Developments
13 Value Chain and Sales Channels Analysis
13.1 Thiabendazole Value Chain Analysis
13.2 Thiabendazole Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Thiabendazole Production Mode & Process
13.4 Thiabendazole Sales and Marketing
13.4.1 Thiabendazole Sales Channels
13.4.2 Thiabendazole Distributors
13.5 Thiabendazole Customers
14 Market Dynamics
14.1 Thiabendazole Industry Trends
14.2 Thiabendazole Market Drivers
14.3 Thiabendazole Market Challenges
14.4 Thiabendazole Market Restraints
15 Key Findings
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Thiabendazole Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2033 (US$ Million)
Table 2. Major Manufacturers of Powder
Table 3. Major Manufacturers of Liquid
Table 4. Global Thiabendazole Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2033 (US$ Million)
Table 5. Global Thiabendazole Revenue by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 6. Global Thiabendazole Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Thiabendazole Revenue Market Share by Region (2018-2023)
Table 8. Global Thiabendazole Revenue by Region (2024-2033) & (US$ Million)
Table 9. Global Thiabendazole Revenue Market Share by Region (2024-2033)
Table 10. Global Thiabendazole Sales Quantity by Region: 2018 VS 2022 VS 2033 (MT)
Table 11. Global Thiabendazole Sales by Region (2018-2023) & (MT)
Table 12. Global Thiabendazole Sales Market Share by Region (2018-2023)
Table 13. Global Thiabendazole Sales by Region (2024-2033) & (MT)
Table 14. Global Thiabendazole Sales Market Share by Region (2024-2033)
Table 15. Global Thiabendazole Production Value Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 16. Global Thiabendazole Production Value by Region (2018-2023) & (US$ Million)
Table 17. Global Thiabendazole Production Value Market Share by Region (2018-2023)
Table 18. Global Thiabendazole Production Value by Region (2024-2033) & (US$ Million)
Table 19. Global Thiabendazole Production Value Market Share by Region (2024-2033)
Table 20. Global Thiabendazole Production Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (MT)
Table 21. Global Thiabendazole Production by Region (2018-2023) & (MT)
Table 22. Global Thiabendazole Production Market Share by Region (2018-2023)
Table 23. Global Thiabendazole Production by Region (2024-2033) & (MT)
Table 24. Global Thiabendazole Production Market Share by Region (2024-2033)
Table 25. Global Thiabendazole Sales Quantity by Manufacturers (2018-2023) & (MT)
Table 26. Global Thiabendazole Sales Quantity Share by Manufacturers (2018-2023)
Table 27. Global Thiabendazole Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 28. Global Thiabendazole Revenue Share by Manufacturers (2018-2023)
Table 29. Global Thiabendazole Price by Manufacturers 2018-2023 (USD/MT)
Table 30. Global Key Players of Thiabendazole, Industry Ranking, 2021 VS 2022
Table 31. Global Thiabendazole Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Thiabendazole by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thiabendazole as of 2022)
Table 33. Global Key Manufacturers of Thiabendazole, Manufacturing Base Distribution and Headquarters
Table 34. Global Key Manufacturers of Thiabendazole, Product Offered and Application
Table 35. Global Key Manufacturers of Thiabendazole, Date of Enter into This Industry
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Thiabendazole Sales Quantity by Type (2018-2023) & (MT)
Table 38. Global Thiabendazole Sales Quantity by Type (2024-2033) & (MT)
Table 39. Global Thiabendazole Sales Quantity Share by Type (2018-2023)
Table 40. Global Thiabendazole Sales Quantity Share by Type (2024-2033)
Table 41. Global Thiabendazole Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Thiabendazole Revenue by Type (2024-2033) & (US$ Million)
Table 43. Global Thiabendazole Revenue Share by Type (2018-2023)
Table 44. Global Thiabendazole Revenue Share by Type (2024-2033)
Table 45. Thiabendazole Price by Type (2018-2023) & (USD/MT)
Table 46. Global Thiabendazole Price Forecast by Type (2024-2033) & (USD/MT)
Table 47. Global Thiabendazole Sales Quantity by Application (2018-2023) & (MT)
Table 48. Global Thiabendazole Sales Quantity by Application (2024-2033) & (MT)
Table 49. Global Thiabendazole Sales Quantity Share by Application (2018-2023)
Table 50. Global Thiabendazole Sales Quantity Share by Application (2024-2033)
Table 51. Global Thiabendazole Revenue by Application (2018-2023) & (US$ Million)
Table 52. Global Thiabendazole Revenue by Application (2024-2033) & (US$ Million)
Table 53. Global Thiabendazole Revenue Share by Application (2018-2023)
Table 54. Global Thiabendazole Revenue Share by Application (2024-2033)
Table 55. Thiabendazole Price by Application (2018-2023) & (USD/MT)
Table 56. Global Thiabendazole Price Forecast by Application (2024-2033) & (USD/MT)
Table 57. North America Thiabendazole Revenue by Company (2018-2023) & (US$ Million)
Table 58. North America Thiabendazole Sales Quantity by Company (2018-2023) & (MT)
Table 59. North America Thiabendazole Sales Quantity by Type (2018-2023) & (MT)
Table 60. North America Thiabendazole Sales Quantity by Type (2024-2033) & (MT)
Table 61. North America Thiabendazole Revenue by Type (2018-2023) & (US$ Million)
Table 62. North America Thiabendazole Revenue by Type (2024-2033) & (US$ Million)
Table 63. North America Thiabendazole Sales Quantity by Application (2018-2023) & (MT)
Table 64. North America Thiabendazole Sales Quantity by Application (2024-2033) & (MT)
Table 65. North America Thiabendazole Revenue by Application (2018-2023) & (US$ Million)
Table 66. North America Thiabendazole Revenue by Application (2024-2033) & (US$ Million)
Table 67. North America Thiabendazole Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 68. North America Thiabendazole Revenue by Country (2018-2023) & (US$ Million)
Table 69. North America Thiabendazole Revenue by Country (2024-2033) & (US$ Million)
Table 70. North America Thiabendazole Sales Quantity by Country (2018-2023) & (MT)
Table 71. North America Thiabendazole Sales Quantity by Country (2024-2033) & (MT)
Table 72. Europe Thiabendazole Sales Quantity by Company (2018-2023) & (MT)
Table 73. Europe Thiabendazole Revenue by Company (2018-2023) & (US$ Million)
Table 74. Europe Thiabendazole Sales Quantity by Type (2018-2023) & (MT)
Table 75. Europe Thiabendazole Sales Quantity by Type (2024-2033) & (MT)
Table 76. Europe Thiabendazole Revenue by Type (2018-2023) & (US$ Million)
Table 77. Europe Thiabendazole Revenue by Type (2024-2033) & (US$ Million)
Table 78. Europe Thiabendazole Sales Quantity by Application (2018-2023) & (MT)
Table 79. Europe Thiabendazole Sales Quantity by Application (2024-2033) & (MT)
Table 80. Europe Thiabendazole Revenue by Application (2018-2023) & (US$ Million)
Table 81. Europe Thiabendazole Revenue by Application (2024-2033) & (US$ Million)
Table 82. Europe Thiabendazole Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 83. Europe Thiabendazole Revenue by Country (2018-2023) & (US$ Million)
Table 84. Europe Thiabendazole Revenue by Country (2024-2033) & (US$ Million)
Table 85. Europe Thiabendazole Sales Quantity by Country (2018-2023) & (MT)
Table 86. Europe Thiabendazole Sales Quantity by Country (2024-2033) & (MT)
Table 87. China Thiabendazole Sales Quantity by Company (2018-2023) & (MT)
Table 88. China Thiabendazole Revenue by Company (2018-2023) & (US$ Million)
Table 89. China Thiabendazole Sales Quantity by Type (2018-2023) & (MT)
Table 90. China Thiabendazole Sales Quantity by Type (2024-2033) & (MT)
Table 91. China Thiabendazole Revenue by Type (2018-2023) & (US$ Million)
Table 92. China Thiabendazole Revenue by Type (2024-2033) & (US$ Million)
Table 93. China Thiabendazole Sales Quantity by Application (2018-2023) & (MT)
Table 94. China Thiabendazole Sales Quantity by Application (2024-2033) & (MT)
Table 95. China Thiabendazole Revenue by Application (2018-2023) & (US$ Million)
Table 96. China Thiabendazole Revenue by Application (2024-2033) & (US$ Million)
Table 97. APAC Thiabendazole Sales Quantity by Company (2018-2023) & (MT)
Table 98. APAC Thiabendazole Revenue by Company (2018-2023) & (US$ Million)
Table 99. APAC Thiabendazole Sales Quantity by Type (2018-2023) & (MT)
Table 100. APAC Thiabendazole Sales Quantity by Type (2024-2033) & (MT)
Table 101. APAC Thiabendazole Revenue by Type (2018-2023) & (US$ Million)
Table 102. APAC Thiabendazole Revenue by Type (2024-2033) & (US$ Million)
Table 103. APAC Thiabendazole Sales Quantity by Application (2018-2023) & (MT)
Table 104. APAC Thiabendazole Sales Quantity by Application (2024-2033) & (MT)
Table 105. APAC Thiabendazole Revenue by Application (2018-2023) & (US$ Million)
Table 106. APAC Thiabendazole Revenue by Application (2024-2033) & (US$ Million)
Table 107. APAC Thiabendazole Revenue by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 108. APAC Thiabendazole Revenue by Region (2018-2023) & (US$ Million)
Table 109. APAC Thiabendazole Revenue by Region (2024-2033) & (US$ Million)
Table 110. APAC Thiabendazole Sales Quantity by Region (2018-2023) & (MT)
Table 111. APAC Thiabendazole Sales Quantity by Region (2024-2033) & (MT)
Table 112. Middle East, Africa and Latin America Thiabendazole Sales Quantity by Company (2018-2023) & (MT)
Table 113. Middle East, Africa and Latin America Thiabendazole Revenue by Company (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Thiabendazole Sales Quantity by Type (2018-2023) & (MT)
Table 115. Middle East, Africa and Latin America Thiabendazole Sales Quantity by Type (2024-2033) & (MT)
Table 116. Middle East, Africa and Latin America Thiabendazole Revenue by Type (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Thiabendazole Revenue by Type (2024-2033) & (US$ Million)
Table 118. Middle East, Africa and Latin America Thiabendazole Sales Quantity by Application (2018-2023) & (MT)
Table 119. Middle East, Africa and Latin America Thiabendazole Sales Quantity by Application (2024-2033) & (MT)
Table 120. Middle East, Africa and Latin America Thiabendazole Revenue by Application (2018-2023) & (US$ Million)
Table 121. Middle East, Africa and Latin America Thiabendazole Revenue by Application (2024-2033) & (US$ Million)
Table 122. Middle East, Africa and Latin America Thiabendazole Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 123. Middle East, Africa and Latin America Thiabendazole Revenue by Country (2018-2023) & (US$ Million)
Table 124. Middle East, Africa and Latin America Thiabendazole Revenue by Country (2024-2033) & (US$ Million)
Table 125. Middle East, Africa and Latin America Thiabendazole Sales Quantity by Country (2018-2023) & (MT)
Table 126. Middle East, Africa and Latin America Thiabendazole Sales Quantity by Country (2024-2033) & (MT)
Table 127. Kenvos Biotech Company Information
Table 128. Kenvos Biotech Description and Overview
Table 129. Kenvos Biotech Thiabendazole Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2018-2023)
Table 130. Kenvos Biotech Thiabendazole Products and Services
Table 131. Kenvos Biotech Thiabendazole SWOT Analysis
Table 132. Kenvos Biotech Recent Development
Table 133. Merial U.S. Company Information
Table 134. Merial U.S. Description and Overview
Table 135. Merial U.S. Thiabendazole Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2018-2023)
Table 136. Merial U.S. Thiabendazole Products and Services
Table 137. Merial U.S. Thiabendazole SWOT Analysis
Table 138. Merial U.S. Recent Development
Table 139. Jiangsu Noon Crop Science Company Information
Table 140. Jiangsu Noon Crop Science Description and Overview
Table 141. Jiangsu Noon Crop Science Thiabendazole Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2018-2023)
Table 142. Jiangsu Noon Crop Science Thiabendazole Products and Services
Table 143. Jiangsu Noon Crop Science Thiabendazole SWOT Analysis
Table 144. Jiangsu Noon Crop Science Recent Development
Table 145. CTS Group Company Information
Table 146. CTS Group Description and Overview
Table 147. CTS Group Thiabendazole Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2018-2023)
Table 148. CTS Group Thiabendazole Products and Services
Table 149. CTS Group Thiabendazole SWOT Analysis
Table 150. CTS Group Recent Development
Table 151. AKITA KONNO CO., LTD Company Information
Table 152. AKITA KONNO CO., LTD Description and Overview
Table 153. AKITA KONNO CO., LTD Thiabendazole Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2018-2023)
Table 154. AKITA KONNO CO., LTD Thiabendazole Products and Services
Table 155. AKITA KONNO CO., LTD Thiabendazole SWOT Analysis
Table 156. AKITA KONNO CO., LTD Recent Development
Table 157. Shanghai Skyblue Chemical Co., Ltd. Company Information
Table 158. Shanghai Skyblue Chemical Co., Ltd. Description and Overview
Table 159. Shanghai Skyblue Chemical Co., Ltd. Thiabendazole Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2018-2023)
Table 160. Shanghai Skyblue Chemical Co., Ltd. Thiabendazole Products and Services
Table 161. Shanghai Skyblue Chemical Co., Ltd. Thiabendazole SWOT Analysis
Table 162. Shanghai Skyblue Chemical Co., Ltd. Recent Development
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Thiabendazole Distributors List
Table 166. Thiabendazole Customers List
Table 167. Thiabendazole Market Trends
Table 168. Thiabendazole Market Drivers
Table 169. Thiabendazole Market Challenges
Table 170. Thiabendazole Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Thiabendazole Product Picture
Figure 2. Global Thiabendazole Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Thiabendazole Market Share by Type in 2022 & 2033
Figure 4. Powder Product Picture
Figure 5. Liquid Product Picture
Figure 6. Global Thiabendazole Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Thiabendazole Market Share by Application in 2022 & 2033
Figure 8. Preservative
Figure 9. Antifungal Agent
Figure 10. Antiparasitic Agent
Figure 11. Other
Figure 12. Thiabendazole Report Years Considered
Figure 13. Global Thiabendazole Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Thiabendazole Revenue 2018-2033 (US$ Million)
Figure 15. Global Thiabendazole Revenue Market Share by Region in Percentage: 2022 Versus 2033
Figure 16. Global Thiabendazole Sales Quantity 2018-2033 (MT)
Figure 17. Global Thiabendazole Sales Quantity Market Share by Region (2018-2023)
Figure 18. Global Thiabendazole Sales Quantity Market Share by Region (2024-2033)
Figure 19. North America Thiabendazole Sales Quantity YoY (2018-2033) & (MT)
Figure 20. North America Thiabendazole Revenue YoY (2018-2033) & (US$ Million)
Figure 21. Europe Thiabendazole Sales Quantity YoY (2018-2033) & (MT)
Figure 22. Europe Thiabendazole Revenue YoY (2018-2033) & (US$ Million)
Figure 23. China Thiabendazole Sales Quantity YoY (2018-2033) & (MT)
Figure 24. China Thiabendazole Revenue YoY (2018-2033) & (US$ Million)
Figure 25. APAC Thiabendazole Sales Quantity YoY (2018-2033) & (MT)
Figure 26. APAC Thiabendazole Revenue YoY (2018-2033) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Thiabendazole Sales Quantity YoY (2018-2033) & (MT)
Figure 28. Middle East, Africa and Latin America Thiabendazole Revenue YoY (2018-2033) & (US$ Million)
Figure 29. Global Thiabendazole Production Value by Region: 2018 VS 2022 VS 2033 (US$ Million)
Figure 30. Global Thiabendazole Production Value Market Share by Region in Percentage: 2022 Versus 2033
Figure 31. Global Thiabendazole Capacity, Production and Utilization (2018-2033) & (MT)
Figure 32. Global Thiabendazole Production by Region: 2018 VS 2022 VS 2033 (MT)
Figure 33. Global Thiabendazole Production Market Share by Region in Percentage: 2022 Versus 2033
Figure 34. Thiabendazole Production Growth Rate in North America (2018-2033) & (MT)
Figure 35. Thiabendazole Production Growth Rate in Europe (2018-2033) & (MT)
Figure 36. Thiabendazole Production Growth Rate in Japan (2018-2033) & (MT)
Figure 37. Thiabendazole Production Growth Rate in China (2018-2033) & (MT)
Figure 38. Thiabendazole Production Growth Rate in South Korea (2018-2033) & (MT)
Figure 39. Thiabendazole Production Growth Rate in India (2018-2033) & (MT)
Figure 40. The Top 10 and Top 5 Players Market Share by Thiabendazole Sales Quantity in 2022
Figure 41. The Top 10 and Top 5 Players Market Share by Thiabendazole Revenue in 2022
Figure 42. Thiabendazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 43. Global Thiabendazole Sales Quantity Market Share by Type (2018-2033)
Figure 44. Global Thiabendazole Revenue Market Share by Type (2018-2033)
Figure 45. Global Thiabendazole Sales Quantity Market Share by Application (2018-2033)
Figure 46. Global Thiabendazole Revenue Market Share by Application (2018-2033)
Figure 47. North America Thiabendazole Revenue Market Share by Company in 2022
Figure 48. North America Thiabendazole Sales Quantity Market Share by Company in 2022
Figure 49. North America Thiabendazole Sales Quantity Market Share by Type (2018-2033)
Figure 50. North America Thiabendazole Revenue Market Share by Type (2018-2033)
Figure 51. North America Thiabendazole Sales Quantity Market Share by Application (2018-2033)
Figure 52. North America Thiabendazole Revenue Market Share by Application (2018-2033)
Figure 53. North America Thiabendazole Revenue Share by Country (2018-2033)
Figure 54. North America Thiabendazole Sales Quantity Share by Country (2018-2033)
Figure 55. U.S. Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 56. Canada Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 57. Europe Thiabendazole Sales Quantity Market Share by Company in 2022
Figure 58. Europe Thiabendazole Revenue Market Share by Company in 2022
Figure 59. Europe Thiabendazole Sales Quantity Market Share by Type (2018-2033)
Figure 60. Europe Thiabendazole Revenue Market Share by Type (2018-2033)
Figure 61. Europe Thiabendazole Sales Quantity Market Share by Application (2018-2033)
Figure 62. Europe Thiabendazole Revenue Market Share by Application (2018-2033)
Figure 63. Europe Thiabendazole Revenue Share by Country (2018-2033)
Figure 64. Europe Thiabendazole Sales Quantity Share by Country (2018-2033)
Figure 65. Germany Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 66. France Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 67. U.K. Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 68. Italy Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 69. Russia Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 70. China Thiabendazole Sales Quantity Market Share by Company in 2022
Figure 71. China Thiabendazole Revenue Market Share by Company in 2022
Figure 72. China Thiabendazole Sales Quantity Market Share by Type (2018-2033)
Figure 73. China Thiabendazole Revenue Market Share by Type (2018-2033)
Figure 74. China Thiabendazole Sales Quantity Market Share by Application (2018-2033)
Figure 75. China Thiabendazole Revenue Market Share by Application (2018-2033)
Figure 76. APAC Thiabendazole Sales Quantity Market Share by Company in 2022
Figure 77. APAC Thiabendazole Revenue Market Share by Company in 2022
Figure 78. APAC Thiabendazole Sales Quantity Market Share by Type (2018-2033)
Figure 79. APAC Thiabendazole Revenue Market Share by Type (2018-2033)
Figure 80. APAC Thiabendazole Sales Quantity Market Share by Application (2018-2033)
Figure 81. APAC Thiabendazole Revenue Market Share by Application (2018-2033)
Figure 82. APAC Thiabendazole Revenue Share by Region (2018-2033)
Figure 83. APAC Thiabendazole Sales Quantity Share by Region (2018-2033)
Figure 84. Japan Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 85. South Korea Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 86. China Taiwan Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 87. Southeast Asia Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 88. India Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 89. Middle East, Africa and Latin America Thiabendazole Sales Quantity Market Share by Company in 2022
Figure 90. Middle East, Africa and Latin America Thiabendazole Revenue Market Share by Company in 2022
Figure 91. Middle East, Africa and Latin America Thiabendazole Sales Quantity Market Share by Type (2018-2033)
Figure 92. Middle East, Africa and Latin America Thiabendazole Revenue Market Share by Type (2018-2033)
Figure 93. Middle East, Africa and Latin America Thiabendazole Sales Quantity Market Share by Application (2018-2033)
Figure 94. Middle East, Africa and Latin America Thiabendazole Revenue Market Share by Application (2018-2033)
Figure 95. Middle East, Africa and Latin America Thiabendazole Sales Quantity Share by Country (2018-2033)
Figure 96. Middle East, Africa and Latin America Thiabendazole Revenue Share by Country (2018-2033)
Figure 97. Brazil Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 98. Mexico Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 99. Turkey Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 100. Israel Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 101. GCC Countries Thiabendazole Revenue (2018-2033) & (US$ Million)
Figure 102. Thiabendazole Value Chain
Figure 103. Thiabendazole Production Process
Figure 104. Channels of Distribution (Direct Vs Distribution)
Figure 105. Distributors Profiles
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed